Introduction {#sec1}
============

The outbreak of the coronavirus 2019 disease (COVID-19) pandemic has strained the health care system in a variety of localities across the globe. In Italy (the European disease epicenter at the time of this writing), intensive care is required for \>15% of infected patients,[@bib1] and the number of hospital beds has been increased by 50% to meet care needs.[@bib2] COVID-19 is highly infectious, and a single patient typically infects 2 to 4 additional persons depending on level of isolation.[@bib3]^,^[@bib4] In Italy alone, an additional 20,000 health care workers are needed to staff the patient surge, resulting in the shunting of nonintensive care units and noninternal medicine health care providers into the inpatient medicine care space from other specialties.[@bib5] Furthermore, physicians and other providers are at especially high risk of infection---treating physicians comprised 29% off those hospitalized in a study of 138 patients in Wuhan, China---and must be replaced and cared for by their colleagues.[@bib6]

Radiation oncology is not on the frontline of this pandemic but is directly affected by the disease through anticipatory reductions in staffing to reduce exposure risks, quarantine of infected or exposed providers, and reallocation of the workforce as providers are called upon to reinforce other specialties. Absence of a certain radiation oncology subspecialist or specialty staff member due to these factors could result in suboptimal care or lack of availability of certain types of specialty care procedures like stereotactic body radiation therapy (SBRT).[@bib7]^,^[@bib8] Patients with cancer are also at higher risk of fatality from infection,[@bib9]^,^[@bib10] which further underscores the need for increased efforts to minimize transmission within the radiation oncology department to protect these at risk patients. To maximize the availability of staff members, as well as to limit the exposure risks amid staff and oncology patients incurred through common interactions such as in-person SBRT coverage, digital care and coverage techniques must be implemented.

Based on the desired use of remote techniques like telemedicine during the COVID-19 pandemic,[@bib11]^,^[@bib12] a novel, digital method to provide physician SBRT coverage for image review was created and implemented in our department. Ease of use and HIPAA compliance were required design features for the deployment of this remote SBRT technology. Equally important was the widespread accessibility of this approach both within our multicenter network and in other clinic systems facing parallel staffing and exposure challenges. Thus, we used a commercially available combination of software and hardware to ensure broad reproducibility.

The goal of our remote SBRT coverage technique was to provide reliable, timely, and similar quality specialty care for our patients to reduce the relative risk of infection in our department by encouraging physical distancing among personnel and oncology patients. We also aimed to provide a mechanism for our physicians and specialty staff to be allocated elsewhere in the hospital while continuing coverage for radiation oncology care. Here we describe the composition, implementation, and reliability of a digital remote SBRT coverage technique in our radiation oncology department, as well as how it is perceived by our SBRT care team.

Methods {#sec2}
=======

At pre--COVID-19 baseline, our daily SBRT coverage team consists of 2 radiation therapists, a medical physicist, and a radiation oncologist. Department policies, developed from national guidelines, require physician presence at every fraction for fusion review, image approval, and to direct treatment, although physics presence is required for all first-fraction treatments to review setup, image registration, motion management, setup corrections, and troubleshooting.[@bib13]^,^[@bib14] Apart from these specified roles, both physicians and physicists must also remain available within the department at all times during treatment delivery. Our department delivers an average of 10 to 15 SBRT treatments per day, the majority of which take place on a specialty stereotactic treatment unit, Edge (Varian Medical Systems, Palo Alto, CA). The typical workflow of coverage is as follows. The patient is set up on the table to marks by the therapy team, and a cone beam computed tomography (CBCT) is obtained with initial positional match performed by the therapists. The physician is then called and verifies the setup, the shift is sent, and the physician verifies all subsequent images (kV/kV, fluoroscopy, etc) before delivery. At first fraction, a physicist is present at time of set up and through delivery. At first (and subsequent) fractions, the physician is called to the machine after initial CBCT match.

To enable transition to remote SBRT coverage in the setting of a global pandemic requiring physical distancing between persons, a commercial grade frame grabber (DVI2USB 3.0, Epiphan Video, Palo Alto, CA) capable of capturing screen resolutions of 1,900 × 1,200 at 60 fps was connected to the digital video interface (DVI) port on the treatment console through a DVI cord splitter, grabbing the entire display screen from the imaging (treatment console) computer on the Edge. This was then projected into a secondary computer via a USB cable connection between the frame grabber and secondary computer. Using an enterprise installation of Microsoft Teams (Microsoft, Redmond, WA), a video call was placed from the secondary computer and the secondary computer's screen was shared (displaying the grabbed treatment console screen) with the covering physician in real time. Microsoft Teams is behind the university's firewall and is within the university's HIPAA compliant Office 365 package. The covering physician can answer the Teams call using either a desktop computer, laptop, tablet, or mobile device. The physician and the treatment machine team (therapists and physicists) must have audio communication to properly communicate; this was fully enabled as long as the device they answer from has audio and microphone capability. To ensure the covering physician has adequate visualization of the treatment images and setup review, the physician can control the secondary computer's mouse via the Microsoft Teams application. If at any time, an SBRT team member feels uncomfortable with the remote physician process, the physician comes to the machine for an in-person review. The process is illustrated in [Fig 1](#fig1){ref-type="fig"}.Figure 1Process map of the remote stereotactic body radiation therapy coverage workflow. *Abbreviation*: CBCT = cone beam computed tomography.

After implementation of the above process, we sought to evaluate the reliability, timeliness, and quality of our remote SBRT coverage system. Reliability was determined by evaluating the frequency and types of process failures that occurred during the first 15 SBRT fractions completed using remote coverage with the novel system. A list of potential failure modes that were recorded is available in [Table E1](#appsec1){ref-type="sec"}, <https://doi.org/10.1016/j.adro.2020.04.012>.

Apart from reliability, we also evaluated the timeliness of remote coverage compared with contemporaneous fractions delivered using our traditional, in-person coverage system. Using the treatment timing stamps from the record and verify system (Aria, Varian, Palo Alto, CA), the time from CBCT acquisition (the time point at which the physician would otherwise be physically called to the machine) to treatment was calculated for 15 fractions after remote SBRT coverage implementation. For comparison, time from CBCT to treatment was also gathered for 15 fractions delivered in the weeks directly preceding remote SBRT coverage. Similar treatment sites were selected for the time analysis before and after remote coverage implementation to limit variations in expected duration. These time stamps represent when the covering physician was contacted and how long they were present at the machine or present on the Teams call.

In addition to reliability and timeliness, we compared both the quantitative and subjective quality of audio and visual (A/V) connection for the remote SBRT coverage platform. Our specific concerns were potential for loss of A/V quality and potential system lag that could degrade coverage quality. Quantitative evaluation of overall A/V quality included comparison of treatment console images versus the physician's shared screen images using cross-correlation image registration metrics. Image lag was tested similarly, using cross-correlation over time to establish when the frame recorded on the physician's computer matched the secondary sharing computer's image frame. The time for the physician's computer to match the secondary computer was the image lag. With regards to subjective A/V quality, physicians, physicists, and therapists were all surveyed after each SBRT fraction, asking each group to rate A/V quality using a Likert scale ([Fig 2](#fig2){ref-type="fig"}).Figure 2Survey questions and responses. ^∗^The responses were statistically different than idealized answers of 5. *P* = .013. *Abbreviations*: MP = medical physicists; RO = radiation oncologists; RTT = radiation therapists; SBRT = stereotactic body radiation therapy.

Finally, we evaluated team member comfort with the novel remote SBRT process. The final question in the postfraction survey administered to all 3 personnel groups involved in the SBRT treatment process was "What was your comfort level with this case compared with how it would be in person?" Responses were again recorded using a 5-point Likert scale.

All statistical analyses were completed using SPSS version 26.0 (IBM Corp, Armonk, NY). For analysis of survey Likert scale data, paired control comparison values of "5" were assumed for all data points, given that surveyed individuals were asked to scale responses such that 1 was "very poor" and 5 was "same as if physician were at the machine." Unpaired and paired *t* tests were used for the comparative analyses for the timing data and survey responses, respectively.

This research was approved by our institutional review board (no. 202004015).

Results {#sec3}
=======

Using a commercially available frame grabber and collaboration platform, we were able to successfully place video calls to the covering physician, sharing the treatment console's imaging screen, for all 15 SBRT coverage calls. During all 15 remote SBRT coverage calls, a call was never was lost nor were there any noticeable glitches in audio or visual quality. Our physician team was also reliable in terms of responsiveness, never needing to be called more than twice with prompt callback if missed.

Remote SBRT physician coverage was successfully used for 14 out of the first sequential 15 treatment fractions. We observed occurrence of 3 system failures from our predetermined set of potential failure modes during the first 15 cases implementing remote SBRT coverage. The first failure was a near-miss for treatment time out (case description and patient identification), which was not initially performed as planned before setup confirmation (preferred timing) but was detected and performed before delivery. The second failure was a distracted physician during remote SBRT coverage. This was detected by the treating therapists, who reminded the physician to not multitask during SBRT, with correction before delivery. The final failure was a treating physician being uncomfortable with visualization and ability to communicate changes for an abdominal gating case during the confirmation of the gating windows and fiducial fluoroscopy tracking, requiring the physician to come to the machine to clarify setup. This resulted in a physician comfort level of 2, or poor.

The disease sites treated for the reported first 15 remote coverage fractions were abdomen (n = 4), bony extremity (n = 4), brain (n = 3), spine (n = 2), lung (n = 1), and neck (n = 1). The comparison cases selected from the preceding weeks using in-person physician coverage were intentionally selected to be of an identical disease site distribution.

The average time from CBCT to the time of treatment for the 15 fractions before implementation was 8.74 ± 2.41 minutes (median 7.93 minutes). The average time from CBCT to the time of treatment for the 15 fractions after implementation was 8.51 ± 3.41 minutes (median 7.48 minutes). These were not statistically different (*P* = .504). A distribution of response times are shown in [Figure 3](#fig3){ref-type="fig"}. The 2 cases requiring the most time after remote treatment implementation were the abdominal gating case, where the physician ultimately came to the machine, and an additional abdominal case where confirmation of setup required comparison to the simulation 4-dimensional computed tomography image set. When excluding these 2 longest remote coverage cases ([Fig 3](#fig3){ref-type="fig"}), the average time for remote coverage was reduced to 7.28 ± 1.39 minutes (*P* = .088 for comparison to in-person coverage). The median amount of time that physicians were on the remote coverage Teams call was 4.43 minutes.Figure 3Physician coverage times before remote stereotactic body radiation therapy coverage (left) and after remote stereotactic body radiation therapy coverage implementation (right). The red plus signs (+) are statistical outliers. *Abbreviation*: CBCT = cone beam computed tomography.

In terms of quantitative image quality, the cross correlation between the treatment console's imaging screen and the shared frame grabbed screen via Microsoft Teams was R = 0.96. The lag in Teams video sharing was 0.05 seconds (50 ms). An example screenshot from a physician's mobile device (iPhone X) during remote coverage is shown in [Figure 4](#fig4){ref-type="fig"}. Two-finger pinch zoom-in and zoom-out was also feasible on touch-screen devices, without perceptible lag. A demonstration of the A/V quality and the workflow can be viewed in [Video E1](#appsec1){ref-type="sec"}.Figure 4Example of covering physician's view on mobile device (iPhone X).

The remote SBRT survey questions and responses for A/V quality and level of comfort are shown in [Figure 2](#fig2){ref-type="fig"}. The only category that was statistically significantly different from in-person coverage was physician comfort ([Fig 2](#fig2){ref-type="fig"}, *P* = .013). The lowest ranked comfort level was 2, which occurred once. There were 5 responses with scores of 4, and the majority of these scores were because the physician would have ideally changed a windowing level or fusion review visualization setting (ie, floating vs gray/white overlay vs checker-box). Nevertheless, the median response was 5 across all categories, including for audio quality.

Discussion {#sec4}
==========

We have successfully implemented remote SBRT physician coverage within our department for a variety of treatment sites. The tools that we use are available to most radiation oncology departments and can be implemented quickly with a few wire connections and installations of commercial applications. Remote SBRT coverage will allow for flexibility in response as staffing resources are shunted or reallocated during the COVID-19 crisis, while providing similar quality to in-person SBRT coverage. All members of the treatment team received the process positively and were invested in making improvements as we continued to refine and gain experience with the process.

Remote SBRT coverage is feasible with minimal observed potential failure modes based on our initial implementation data. Of the first 15 remote coverage cases attempted, only 1 case ultimately required physician presence. Specifically, nuances of communication using remote instructions for gating windows for a gated abdominal case led to physician discomfort with remote coverage, and the physician instead opted to be physically present at the console for more direct communication. Other observed failure modes were a distracted physician (multiple phone messages while covering via Teams mobile app call) and a nearly missed pretreatment time-out. Both of these were detected and corrected before treatment. Formal failure mode and effects analysis is the optimal approach before implementation of novel technologies in a medical environment.[@bib15] However, given the urgency of creating a remote coverage process in the pandemic setting, this will instead be formally carried out after remote SBRT implementation.

With regards to timeliness, remote SBRT coverage compared favorably with our in-person process. Time delays are critical to avoid for successful deployment of the tool, as this would prolong patient time on-table, which can result in loss of setup accuracy.[@bib16] We found that the time of CBCT to the time of treatment was not statistically different for remote coverage compared with in-person coverage. It is important to note that during this short period of investigation most of the cases analyzed were not our institution's typical SBRT disease sites (majority lung and brain), lending to the possibility that pretreatment coverage could be faster for standard SBRT disease sites compared with our current process of requiring the physician to be physically present. Importantly, remote coverage physically removed physicians from the machine, which would otherwise be an average of 4.5 minutes for in-person coverage at each case. This may reduce the relative risk of infectious exposure across personnel and patients. Physicians were able to remote review from areas in the department such as nursing wings, their office, and outside a consult room. We also found it helpful to inform the covering physician when the treatment team was bringing the patient into the room, allowing the physician to expect a call and increase the answer rate.

Our image quality degradation through Microsoft Teams via the frame grabber was minimal and maintained high correlation within the hospital network, meaning the images were almost identical. The lag was 50 milliseconds, which is in the range of what is perceived as "instantaneous action" to a user based on published literature.[@bib17]^,^[@bib18] Our image quality metrics as determined by posttreatment surveys demonstrate noninferiority to the physician's visual perception if he or she were present at the machine.

The comfort level among all members of the treatment team approached the in-person SBRT coverage comfort levels, demonstrating that our SBRT team felt comfortable proceeding with treatment despite not having a physician physically present. The lowest comfort level reported for any fraction was a 2, due to inconsistencies between the CBCT and fluoroscopic gated images, resulting in the longest CBCT to treatment time. Despite a low comfort level, we were able to correctly identify that the physician was needed at the machine and had minimal wait time for the physician to be present (approximately a minute or less). In the future, we look to identify cases where remote SBRT coverage may be challenging, such as first fraction abdominal gating cases or for lesions that have high potential for poor detectability even if in person (eg, peri-diaphragmatic lung lesions). Additional time-outs during this process are necessary to ensure physicians have all needed information. Ordinarily, time out is performed before the patient is placed on the table and again when physician arrives for coverage. With in-person coverage, the physician has the opportunity to pull up patient charts and supplementary imaging alongside the treatment console on a separate computer from the Microsoft Teams computer. In the remote setting, especially by mobile app, a second timeout to transmit this information about the case to the physician is critical. Having available resources at the ready, including prior fraction notes, planning scans, and so on, to answer whatever questions that the physician has may be helpful. Not having additional resources at the ready on the secondary computer resulted in the second slowest outlier seen in [Figure 3](#fig3){ref-type="fig"}. Additional challenges include the greater importance of using direct verbal communication, as common nonverbal cues are lost with remote coverage. Limiting distractions from competing physician tasks is also critical to ensure quality and future steps may include a formal coverage script where physicians maintain an active verbal role in the process to ensure continued attentiveness.

Future steps in our process include performing a formal failure mode and effects analysis of remote SBRT coverage for our physicians. We would also like to perform a study investigating remote coverage differences for a larger set of patients over a longer period of time. This work allows us to explore avenues of real-time training and recording across our multi-institutional sites during deployment of new techniques for debrief and feedback. It also provides a platform for real-time collaboration across multiple individuals with expertise in a variety disease sites despite not being physically available at the time of treatment. At this current stage, we were able to quickly implement this novel technology, performing a brief yet informative and important study in the management of COVID-19 for the health care system.

Conclusion {#sec5}
==========

In our study, we were able to provide remote SBRT coverage that is of high visual and audio quality, reliable, timely, and similar to in-person physician SBRT coverage. Because of this, we may reduce the relative risk of transmitting COVID-19 among our colleagues and patients. Our physicians were able to perform remote SBRT coverage in various locations in our department and hospital, meaning coverage is possible even if physicians are allocated to other areas in the hospital. Remote coverage permits continued high-quality care for our oncology patients, maximizing physicians as resources for other types of patient care during the COVID-19 crisis, and minimizes exposure risk to our staff members and patients.
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